3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Head & Neck
1
Conditions
Stomatitis
1
Neuroendocrine Tumors
1
Neoplasms
1
Mucositis
1
Mouth Neoplasms
1
Lymphoma
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Small Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Radiotherapy
7
Cisplatin
6
Fibroblast Growth Factor 7
3
Water
2
Radiation
2
Low-Level Light Therapy
2
Injections
2
peppermint oil
1
pegfilgrastim
1
oxycodone-acetaminophen
1
kang-lai-te
1
cyclohexaneacetic acid
1
brilacidin
1
anise oil
1
acetaminophen, hydrocodone drug combination
1
Xylitol
1
Tramadol
1
Therapeutics
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Sorbic Acid
1
Selenomethionine
1
Saline Solution
1
RRx-001
1
Poloxamer
1
Phosphatidylinositol 3-Kinases
1
Pain Management
1
Neck Dissection
1
Methods
1
Ketamine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Mucositis
×
RRx-001
×
Clear all
NCT03515538
2024-11-04
PREVLAR
EpicentRx, Inc.
Phase 2
Completed
53 enrolled
15 charts